|1.||Friedland, H David: 15 articles (01/2015 - 12/2010)|
|2.||Jandourek, Alena: 7 articles (05/2015 - 04/2011)|
|3.||Biek, Donald: 7 articles (03/2014 - 10/2010)|
|4.||Eckburg, Paul B: 7 articles (02/2014 - 12/2010)|
|5.||Cole, Phillip: 6 articles (08/2015 - 08/2014)|
|6.||Llorens, Lily: 6 articles (02/2014 - 12/2010)|
|7.||Rybak, Michael J: 5 articles (12/2015 - 06/2012)|
|8.||File, Thomas M: 5 articles (02/2015 - 12/2010)|
|9.||Talbot, George H: 5 articles (04/2011 - 11/2010)|
|10.||Udeani, George: 4 articles (08/2015 - 08/2014)|
05/01/2012 - "The purpose of this study was to evaluate the efficacy of a human simulated dose of ceftaroline fosamil against clinical Enterobacteriaceae in both neutropenic and immunocompetent mouse thigh infection models. "
04/01/2006 - "In subsequent studies we used the neutropenic murine thigh infection model to determine if the magnitude of the free-drug % T>MIC needed for efficacy of PPI-0903 varied among pathogens (including resistant strains). "
01/01/2015 - "Pharmacokinetic-pharmacodynamic analysis for efficacy of ceftaroline fosamil in patients with acute bacterial skin and skin structure infections."
11/01/2014 - "Ceftaroline-Fosamil efficacy against methicillin-resistant Staphylococcus aureus in a rabbit prosthetic joint infection model."
11/01/2013 - "In vivo efficacy of humanized ceftaroline fosamil-avibactam exposures in a polymicrobial infection model."
12/01/2012 - "Efficacy of ceftaroline fosamil in a staphylococcal murine pneumonia model."
04/01/2011 - "Integrated safety summary of FOCUS 1 and FOCUS 2 trials: Phase III randomized, double-blind studies evaluating ceftaroline fosamil for the treatment of patients with community-acquired pneumonia."
12/01/2015 - "Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia with Ceftaroline Fosamil in a Patient with Inhalational Thermal Injury."
09/01/2015 - "Ceftaroline fosamil for community-acquired pneumonia--Authors' reply."
09/01/2015 - "Ceftaroline fosamil for community-acquired pneumonia."
12/01/2013 - "Pharmacokinetic-pharmacodynamic analyses for efficacy of ceftaroline fosamil in patients with community-acquired bacterial pneumonia."
09/01/2014 - "The Clinical Assessment Program and Teflaro Utilization Registry (CAPTURE) is a multicenter registry study of patients treated with ceftaroline fosamil in the United States for ABSSSI or community-acquired bacterial pneumonia. "
08/01/2014 - "Contemporary use of ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia: CAPTURE study experience."
12/01/2013 - "Pharmacokinetic-pharmacodynamic (PK-PD) analyses for efficacy using phase III trial data from patients treated with a ceftaroline fosamil dosing regimen of 600 mg intravenously (i.v.) every 12 h (q12h) for 5 to 7 days for community-acquired bacterial pneumonia (CABP) were conducted. "
03/01/2013 - "Assessment of ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia due to Streptococcus pneumoniae: insights from two randomized trials."
10/01/2010 - "Evaluation of the in vivo efficacy of intramuscularly administered ceftaroline fosamil, a novel cephalosporin, against a methicillin-resistant Staphylococcus aureus strain in a rabbit endocarditis model."
03/01/2014 - "[Role of ceftaroline fosamil in the treatment of bacteremia and infectious endocarditis]."
02/01/2013 - "The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients."
04/01/2011 - "Using this model of infective endocarditis, ceftaroline fosamil and daptomycin demonstrated high bactericidal in vivo activity (reduction of >5 log(10) cfu/g of vegetation) after a 4 day treatment against MSSA, MRSA and GISA strains. "
09/01/2014 - "No clinical trials have investigated the use of ceftaroline fosamil for salvage therapy of methicillin-resistant Staphylococcus aureus bacteremia and endocarditis. "
12/01/2013 - "Efficacy of Ceftaroline Fosamil against Escherichia coli and Klebsiella pneumoniae strains in a rabbit meningitis model."
12/01/2013 - "In this study, the efficacy of ceftaroline fosamil was compared with that of cefepime in an experimental rabbit meningitis model against two Gram-negative strains (Escherichia coli QK-9 and Klebsiella pneumoniae 1173687). "
10/01/2013 - "Efficacy of ceftaroline fosamil against penicillin-sensitive and -resistant streptococcus pneumoniae in an experimental rabbit meningitis model."
|2.||Renal Dialysis (Hemodialysis)